Your browser doesn't support javascript.
loading
Association of amyloid-beta with depression or depressive symptoms in older adults without dementia: a systematic review and meta-analysis.
Twait, Emma L; Wu, Jen-Hao; Kamarioti, Maria; Basten, Maartje; van der Flier, Wiesje M; Gerritsen, Lotte; Geerlings, Mirjam I.
Afiliación
  • Twait EL; Amsterdam UMC, location Vrije Universiteit, Department of General Practice, Van der Boechorststraat 7, Amsterdam, The Netherlands.
  • Wu JH; Amsterdam Public Health; Aging & Later life, and Personalized Medicine, Amsterdam, The Netherlands.
  • Kamarioti M; Amsterdam Neuroscience; Neurodegeneration, and Mood, Anxiety, Psychosis, Stress, and Sleep, Amsterdam, The Netherlands.
  • Basten M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands.
  • van der Flier WM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands.
  • Gerritsen L; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands.
  • Geerlings MI; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands.
Transl Psychiatry ; 14(1): 25, 2024 Jan 15.
Article en En | MEDLINE | ID: mdl-38225253
ABSTRACT
Several lines of evidence have indicated that depression might be a prodromal symptom of Alzheimer's disease (AD). This systematic review and meta-analysis investigated the cross-sectional association between amyloid-beta, one of the key pathologies defining AD, and depression or depressive symptoms in older adults without dementia. A systematic search in PubMed yielded 689 peer-reviewed articles. After full-text screening, nine CSF studies, 11 PET studies, and five plasma studies were included. No association between amyloid-beta and depression or depressive symptoms were found using cerebrospinal fluid (CSF) (0.15; 95% CI -0.08; 0.37), positron emission topography (PET) (Cohen's d 0.09; 95% CI -0.05; 0.24), or plasma (-0.01; 95% CI -0.23; 0.22). However, subgroup analyses revealed an association in plasma studies of individuals with cognitive impairment. A trend of an association was found in the studies using CSF and PET. This systematic review and meta-analysis suggested that depressive symptoms may be part of the prodromal stage of dementia.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Péptidos beta-Amiloides / Depresión / Disfunción Cognitiva Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Límite: Aged / Humans Idioma: En Revista: Transl Psychiatry Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Péptidos beta-Amiloides / Depresión / Disfunción Cognitiva Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Límite: Aged / Humans Idioma: En Revista: Transl Psychiatry Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos